Poland· PL-100376073
Canephron
A medicinal product containing levistici radix + centaurii herba + rosmarini folium, registered in Poland by Bionorica SE.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Levistici radix + Centaurii herba + Rosmarini folium
- Manufacturer
- Bionorica SE
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991391096
- gtin05909991391102
- gtin05909991391119
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/513dcfce-3c0a-47ee-a2ea-bf9cef8621fb GET /v1/drugs/513dcfce-3c0a-47ee-a2ea-bf9cef8621fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki drażowane",
"source": "urpl",
"strength": "18 mg + 18 mg + 18 mg",
"packaging": "05909991391096 ¦ OTC ¦ 130731\n60 tabl.\n05909991391102 ¦ OTC ¦ 130732\n120 tabl.\n05909991391119 ¦ OTC ¦ 130733\n200 tabl.",
"substance": "Levistici radix 18 mg + Centaurii herba 18 mg + Rosmarini folium 18 mg",
"common_name": "Levistici radix + Centaurii herba + Rosmarini folium",
"pl_product_id": "100376073",
"pozwolenie_nr": "25067",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about levistici radix + centaurii herba + rosmarini folium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.